The guide on ILD CTD for APPs is necessary due to the complexity of intertwining autoimmune disorders with the involvement of the interstitial lung. Since certain connective tissue diseases can... Read More
Author: ILD
Education on progressive pulmonary fibrosis (PPF) for advanced practice providers (APPs) has become essential as patients with fibrotic interstitial lung diseases are showing a progressive decline despite the implementation of... Read More
Advanced Practice Providers (APP) have the responsibility of providing coordinated, patient-centered, and evidence-based care across the full spectrum of Interstitial Lung Disease (ILD). APP’s are having an increasely important role... Read More
Management of idiopathic pulmonary fibrosis for advanced practice providers (APPs) involves early detection, precise diagnosis, the prompt start of antifibrotic treatment, and organized and ongoing evaluations of the disease to... Read More
Training advanced practice providers (APP) on interstitial lung disease (ILD) is essential because it intersects multiple dimensions of pulmonary medicine that require disease recognition and evaluation, collaboration with multiple specialties,... Read More